EDGAR Filing Documents for 0001654954-18-007662

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001654954-18-007662

Filing Date

2018-07-13

Accepted

2018-07-13 17:09:06

Documents

Period of Report

2018-07-12

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form6-k_proxy.htm	6-K	19734
2	EXHIBIT 99.1	ex991.htm	EX-99.1	23205
3	EXHIBIT 99.2	ex992.htm	EX-99.2	184857
4	EXHIBIT 99.3	ex993_com.htm	EX-99.3	7656
5	EXHIBIT 99.4	ex994.htm	EX-99.4	4245
6	EXHIBIT 99.5	ex995.htm	EX-99.5	13018
7	EXHIBIT 99.6	ex996.htm	EX-99.6	29354
8	IMAGE	astlogo.jpg	GRAPHIC	3288
9	IMAGE	ex994000.jpg	GRAPHIC	59252
10	IMAGE	ex994001.jpg	GRAPHIC	138901
11	IMAGE	ex994002.jpg	GRAPHIC	71134
12	IMAGE	ex994003.jpg	GRAPHIC	141485
13	IMAGE	intellipharmaceutics_logo.jpg	GRAPHIC	7239
	Complete submission text file	0001654954-18-007662.txt		864175

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2

Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001

Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)